LabCorp Acquires Safe Foods International Holdings

Transaction Expands Capabilities in Food and Beverage product-development and product-integrity BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 23, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced the acquisition of Safe Foods International Holdings, LLC (SFIH)

Covance Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award Two Years in a Row

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 19, 2015-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that Covance Drug Development (“Covance”) has been awarded the 2015 Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award.

LabCorp to Offer New PD-L1 Test for Bristol-Myers Squibb’s OPDIVO® Following Collaboration in Clinical Trial

Test Launch Demonstrates that Combined LabCorp-Covance Capabilities Provide Best in Class Solutions for Development and Commercialization of Diagnostics Linked to Innovative Medicines BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 12, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® )

LabCorp to Follow Pivotal Role in Clinical Trial of Merck’s Keytruda® by Offering PD-L1 Companion Diagnostic

Test Launch Demonstrates that Combined LabCorp-Covance Capabilities Make the Company Best-in-Class Partner for Development and Commercialization of Companion Diagnostics BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 2, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 1, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.

Bode Cellmark Forensics Enters into Service Agreement in Support of Innovative Programs Dedicated to Processing Sexual Assault Kits Nationwide

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 30, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that Bode Cellmark Forensics, a member of the LabCorp Specialty Testing Group , has entered into an agreement with the New York County District Attorney’s Office

Covance to Open Second Current Good Manufacturing Practice (cGMP) Pharmacy in U.S.

Covance is the only CRO to offer cGMP manufacturing in a U.S. Phase I Clinical Research Unit BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 21, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that Covance Drug Development will open a cGMP-compliant pharmacy at

LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 11, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE:LH) announced today that for the period of September 12, 2015 to March 11, 2016 , its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the

LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 10, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced it will participate at the Morgan Stanley Global Healthcare Conference . LabCorp’s presentation is planned for Thursday, September 17, 2015 at 1:30 PM (ET) .

LabCorp Expands Partnership with Perinatal Quality Foundation to Educate Patients and Healthcare Providers about Noninvasive Prenatal Testing

PQF and LabCorp Build On Established Collaboration that Promotes Appropriate Use of Innovative Technologies in Clinical Care BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 3, 2015-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today an expansion of its long-standing